Ranibizumab and bevacizumab for AMD.
Publication
, Journal Article
Cheung, CMG; Wong, TY
Published in: N Engl J Med
December 8, 2011
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
December 8, 2011
Volume
365
Issue
23
Start / End Page
2237
Location
United States
Related Subject Headings
- Male
- Macular Degeneration
- Humans
- General & Internal Medicine
- Female
- Antibodies, Monoclonal
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cheung, C. M. G., & Wong, T. Y. (2011). Ranibizumab and bevacizumab for AMD. N Engl J Med, 365(23), 2237. https://doi.org/10.1056/NEJMc1107895
Cheung, CM Gemmy, and Tien Y. Wong. “Ranibizumab and bevacizumab for AMD.” N Engl J Med 365, no. 23 (December 8, 2011): 2237. https://doi.org/10.1056/NEJMc1107895.
Cheung CMG, Wong TY. Ranibizumab and bevacizumab for AMD. N Engl J Med. 2011 Dec 8;365(23):2237.
Cheung, CM Gemmy, and Tien Y. Wong. “Ranibizumab and bevacizumab for AMD.” N Engl J Med, vol. 365, no. 23, Dec. 2011, p. 2237. Pubmed, doi:10.1056/NEJMc1107895.
Cheung CMG, Wong TY. Ranibizumab and bevacizumab for AMD. N Engl J Med. 2011 Dec 8;365(23):2237.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
December 8, 2011
Volume
365
Issue
23
Start / End Page
2237
Location
United States
Related Subject Headings
- Male
- Macular Degeneration
- Humans
- General & Internal Medicine
- Female
- Antibodies, Monoclonal
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences